Literature DB >> 9294616

Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.

G Packham1, J L Cleveland.   

Abstract

Enforced c-Myc expression promotes continuous, growth factor-independent, cell cycle progression and activates expression of the ornithine decarboxylase (ODC) gene and its promoter. c-Myc-responsiveness of murine ODC is mediated by two conserved c-Myc:Max E-boxes in ODC intron 1. c-Myc and ODC are both required for cell growth and their expression is sequentially induced in G0/G1 cells stimulated with mitogens, yet their expression is not modulated by the cell cycle in proliferating cells. Here we demonstrate that regulation of ODC and its promoter by Interleukin-3 (IL-3) in murine myeloid cells is mediated in part by c-Myc, c-Myc induced ODC through the same transcription start site as IL-3 and, in asynchronously growing cells, maximal activity of the ODC promoter required the intronic c-Myc binding sites. However, induction of ODC following IL-3 stimulation of quiescent cells is mediated by at least two pathways. The first phase of this response was independent of the intronic c-Myc:Max E-boxes and de novo protein synthesis. Sustained induction of the ODC promoter however required the c-Myc:Max binding sites and protein synthesis. Accumulation of c-Myc following stimulation of quiescent cells with IL-3 correlated with the delayed phase of the response. Consistent with a two pathway model of ODC regulation, inducible overexpression of dominant negative form of c-Myc (In373-Myc), which specifically inhibits the c-Myc-Max network, inhibited the delayed, but not immediate, induction of ODC promoter activity in response to IL-3. Dominant negative c-Myc protein also effectively suppressed induction of the endogenous ODC gene by IL-3. Therefore, c-Myc functions as a direct and required-regulator of ODC. These results also suggest a model whereby c-Myc's role in regulating its targets may be to convert a transient, immediate-early, activation event into the persistent induction of gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294616     DOI: 10.1038/sj.onc.1201273

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells.

Authors:  F Flamigni; A Facchini; C Capanni; C Stefanelli; B Tantini; C M Caldarera
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 6.  Ancillary Activity: Beyond Core Metabolism in Immune Cells.

Authors:  Daniel J Puleston; Matteo Villa; Erika L Pearce
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

7.  Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development.

Authors:  Mauricio D Dorfman; Bredford Kerr; Cecilia Garcia-Rudaz; Alfonso H Paredes; Gregory A Dissen; Sergio R Ojeda
Journal:  Endocrinology       Date:  2011-10-25       Impact factor: 4.736

8.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis.

Authors:  P J Greasley; C Bonnard; B Amati
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

9.  Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation.

Authors:  Jonas A Nilsson; Kirsteen H Maclean; Ulrich B Keller; Helene Pendeville; Troy A Baudino; John L Cleveland
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.

Authors:  Antonio L Amelio; Mohammad Fallahi; Franz X Schaub; Min Zhang; Mariam B Lawani; Adam S Alperstein; Mark R Southern; Brandon M Young; Lizi Wu; Maria Zajac-Kaye; Frederic J Kaye; John L Cleveland; Michael D Conkright
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.